Astellas Pharma acquires Potenza Therapeutics in $404.7m deal
Japanese pharmaceutical giant Astellas Pharma has announced the acquisition of US-based Potenza Therapeutics in a significant transaction valued at up to $404.7 million. This strategic move is the culmination of a collaborative partnership established between the two companies in 2015, aimed at advancing novel immuno-oncology (IO) therapies. Under the terms of the acquisition, Astellas has […]